Fig. 3From: Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signalingAlkaloid extract of YHS limited angiogenesis in vivo (a) Antiangiogenic effects of alkaloid extract of YHS in mice. C57BL/6 Mice were subcutaneously injected with 500 μl of a Matrigel mixture containing 50 ng VEGF. The mice treated with various concentrations of alkaloid extract of YHS (a: 0 mg/kg; b: 15 mg/kg; c: 30 mg/kg; d: 60 mg/kg) were euthanized 14 days later and Matrigel plugs were harvested. 4 μm paraffin sections were stained with CD31 (brown) and a representative image is shown, scale bar: 200 μm. b Quantification of relative vessel area (CD31 positive staining). Relative CD31 positive staining treated with 0 mg/kg alkaloid extract of YHS was set as 100%. Data are presented as mean ± SEM. ***, P < 0.001; *, P < 0.05, n = 4, paired t-test. c Representative images of microvessels formation on in vivo CAM model after the treatment of different concentrations of alkaloid extract of YHS (a: 0 μg/ml; b: 10 μg/ml; c: 50 μg/ml; d: 100 μg/ml). d Quantification of number of blood vessels in CAM model. The index was defined as the mean number of visible microvessel with the defined area of drug-containing pellets. Relative blood vessel number treated with 0 μg/ml alkaloid extract of YHS (control) was set as 100%. Data are presented as mean ± SEM. ***, P < 0.001; *, P < 0.05, n = 4, paired t-testBack to article page